The CDC and FDA lifted their recommended pause on Johnson & Johnson’s coronavirus vaccine, finding that the vaccine is safe and effective in preventing the virus and that the benefits outweigh the risks. The agencies initially recommended the pause after six reported cases of blood clots (out of ~7M doses administered).
The New Paper
This story is from the April 26, 2021 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.
